Nyxoah (NASDAQ:NYXH – Get Free Report) and MSP Recovery (NASDAQ:MSPR – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, dividends and analyst recommendations.
Profitability
This table compares Nyxoah and MSP Recovery’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Nyxoah | -543.21% | -163.73% | -80.24% |
| MSP Recovery | -7,328.48% | -326.80% | -81.27% |
Analyst Ratings
This is a breakdown of current ratings for Nyxoah and MSP Recovery, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Nyxoah | 1 | 1 | 2 | 0 | 2.25 |
| MSP Recovery | 1 | 0 | 0 | 0 | 1.00 |
Institutional & Insider Ownership
3.8% of MSP Recovery shares are held by institutional investors. 17.1% of Nyxoah shares are held by company insiders. Comparatively, 50.5% of MSP Recovery shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Earnings and Valuation
This table compares Nyxoah and MSP Recovery”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Nyxoah | $11.33 million | 4.96 | -$101.92 million | ($2.48) | -0.58 |
| MSP Recovery | $9.81 million | 0.04 | -$360.50 million | ($572.83) | 0.00 |
Nyxoah has higher revenue and earnings than MSP Recovery. Nyxoah is trading at a lower price-to-earnings ratio than MSP Recovery, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
Nyxoah has a beta of 1.55, meaning that its share price is 55% more volatile than the S&P 500. Comparatively, MSP Recovery has a beta of -2.38, meaning that its share price is 338% less volatile than the S&P 500.
Summary
Nyxoah beats MSP Recovery on 11 of the 14 factors compared between the two stocks.
About Nyxoah
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
About MSP Recovery
MSP Recovery, Inc. engages in the development of healthcare recoveries and data analytics software. It also focuses on the identification and recoveries of improper payments made by Medicare, Medicaid, and commercial insurance spaces using data and analytics. The company was founded by John H. Ruiz, Frank C. Quesada, and Diana Diaz on July 8, 2014 and is headquartered in Miami, FL.
Receive News & Ratings for Nyxoah Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nyxoah and related companies with MarketBeat.com's FREE daily email newsletter.
